{"disease":{"id":"high-grade-gliomas","name":"high grade gliomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00272350","title":"ZD6474 to Treat Advanced Brain Cancer in Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06740097","title":"Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT04253873","title":"Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"WuHui","has_results":false},{"nct_id":"NCT07210632","title":"Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Eben Rosenthal","has_results":false},{"nct_id":"NCT06660056","title":"A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"GONGCHU Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT03389802","title":"Phase I Study of APX005M in Pediatric Central Nervous System Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Pediatric Brain Tumor Consortium","has_results":true},{"nct_id":"NCT06018363","title":"Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Dushu Lake Hospital Affiliated to Soochow University","has_results":false},{"nct_id":"NCT03904628","title":"Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Lee's Pharmaceutical Limited","has_results":false},{"nct_id":"NCT07331064","title":"Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Sarah Rumler","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}